ROSSARI BIOTECH Q2 FY27 ; NET PROFIT UP 5% AT ₹38.90 CR (YOY), UP 11% (QOQ)

REVENUE UP 19% AT ₹697.60 CR (YOY), FLAT (QOQ) EBITDA UP 21% AT ₹87 CR (YOY), UP 8% (QOQ) MARGINS AT 12.5% VS 12.3% (YOY), VS 11.6% (QOQ)

ROSSARI BIOTECH LIMITED